Core Viewpoint - The integration of medical and engineering fields is becoming a key driver for breakthroughs in high-end medical equipment and biopharmaceutical innovation, particularly in Zhuhai, which is positioned as a strategic hub in the Guangdong-Hong Kong-Macao Greater Bay Area [2]. Event Details - The "Medical-Engineering Integration Annual Conference 2025" will be held from December 26 to 28, 2025, in Zhuhai, Guangdong, aiming to promote high-quality development in the medical-engineering integration sector [2]. - The conference theme is "Jointly Inviting the Bay Area: Medical-Engineering Integration to Inspire the Future," focusing on creating a resource platform for collaboration among government, associations, hospitals, universities, research institutions, investment entities, and enterprises [2]. Organizing Institutions - The conference is guided by the China Medical and Health Culture Association and organized by Beijing Institute of Technology (Zhuhai), Zhuhai Health Bureau, and the Medical-Engineering Integration Branch of the China Medical and Health Culture Association [3]. Conference Highlights - The event will feature top scholars and industry leaders sharing insights on cutting-edge research and industry trends, fostering a collaborative ecosystem for project signing and talent introduction [60]. - A dedicated Zhuhai Medical-Engineering Integration Liaison Office will be established to provide ongoing support and services, including policy consultation and funding connections [60]. Main Content - The agenda includes leadership speeches, high-quality thematic forums, academic dialogues, and an award ceremony for outstanding orthopedic innovation projects [61]. - Resource matching sessions will be organized, including project roadshows and expert evaluations, along with site visits to local leading enterprises [61]. - Policy and service promotion will cover key industry policies in biomedicine, high-end medical equipment, and artificial intelligence [61].

一句话趋势：科技与制造、医疗健康领域持续以案例密度和资金量级双优势主导融资市场。 过去一周，科技与制造领域以超20起案例、多笔5亿元级大额交易成融资核心：半导体设备企业新施诺完成超5亿元A+轮融资；通讯设备研发商昉擎科技斩 获超5亿元Pre-A轮融资；卫星通信企业星联芯通完成逾亿元B轮融资；智能特种机器人企业博清科技获数亿元B轮融资；二维半导体企业原集微完成近亿元 天使轮融资。 医疗健康领域稳健发力，大额交易与细分创新并行：新药研发服务平台康源博创完成2.5亿元B轮融资；恶性肿瘤创新药研发企业伯汇生物获近亿元A+轮融 资；AI驱动新药研发企业哲源科技完成亿级A+轮融资。此外，脑机接口企业阶梯医疗、眼病数字疗法企业集视科技、创新多肽药物研发商成都佩德生物等 细分场景企业均获资本加持，资金聚焦临床价值明确的创新领域。 消费服务领域无新增融资案例，整体延续"硬科技+医疗健康"双主线主导的市场格局。 02、哪些投资机构较为活跃 从机构投资活跃度来看，本周亦庄国投、国科投资较为活跃，各披露2笔投资，主要聚集在科技与制造领域与医疗健康领域。 | 刨投 | | 2025年12月15日-12月21日 国内一级市场活跃 | | ...

0:00 在海南生态软件园，基于人工智能和虚拟现实技术的数字疗法，或可为有"星星的孩子"之称的孤独症患 儿带去希望。（记者 王志锋 董泽扬 孟凡盛） 来源：人民日报客户端 ...

Core Viewpoint - The article discusses the transformative potential of virtual reality (VR) in the medical field, exploring its applications from trauma treatment to neurological rehabilitation, and how technology is reshaping human health [1]. Group 1: Virtual Reality in Medicine - Virtual reality is not just limited to gaming; it has the potential to significantly impact the future of medicine [1]. - The discussion highlights how immersive technologies can reshape the healthcare industry, addressing global challenges such as aging populations and mental health [1]. Group 2: Expert Insights - Dr. Walter Greenleaf, a neuroscientist and expert in virtual reality and digital health from Stanford University, provides insights into the role of VR in cognitive reversal and digital therapies [1][3]. - The conversation is facilitated by Yin Fan, a host from First Financial, indicating a collaboration between academia and media to disseminate knowledge on this topic [3]. Group 3: Broadcast Information - The program featuring this discussion will premiere on September 24 at 22:30 on Dongfang TV and will be rebroadcast on September 27 at 22:00 on First Financial [5].

Core Insights - The 2025 Digital Therapy Conference was held in Haikou from August 15 to 16, focusing on establishing Hainan as a global hub for digital therapy innovation [1] - The conference attracted representatives from government, academia, clinical experts, and industry leaders to discuss the development direction, trends, and collaboration opportunities in digital therapy [1] Industry Overview - Digital therapy is recognized as a key direction for innovation in modern service industries and high-tech sectors, aligning with Hainan's health industry layout within the free trade port [1] - Hainan is leveraging its free trade port policy advantages to systematically promote the development of a collaborative digital healthcare ecosystem [1] Key Developments - The conference released the "Digital Medical Regional Demonstration Application Panorama," which systematically outlines typical demonstration cases across various regions, departments, and indications in China [1] - The event featured a dedicated exhibition area showcasing the "Hainan Digital Therapy Innovation Island Ecosystem," presenting a comprehensive view of digital therapy development from policy, industry, clinical implementation, and user benefits perspectives [1]

Core Viewpoint - Enhua Pharmaceutical reported continuous growth in its operating performance for the first half of 2025, with revenue reaching 3.01 billion yuan, an increase of 8.93% year-on-year, and a net profit attributable to shareholders of 700 million yuan, up 11.38% year-on-year [1] Financial Performance - The company achieved an operating revenue of 3.01 billion yuan, reflecting an 8.93% increase compared to the same period last year [1] - The net profit attributable to shareholders was 700 million yuan, marking an 11.38% year-on-year growth [1] - The net profit after deducting non-recurring gains and losses was 699 million yuan, which is a 10.33% increase year-on-year [1] R&D Investment - Enhua Pharmaceutical invested approximately 395 million yuan in research and development, representing a 23.97% increase compared to the previous year [2] - The company has over 70 ongoing research projects in the pipeline and holds the largest product line in the central nervous system drug sector in China [2] Innovative Drug Development - The company has 17 innovative drug projects under development, including 1 project in Phase III clinical trials and 2 projects in Phase II clinical trials [3] - Collaborations include partnerships with San Sheng Pharmaceutical and Harvard Medical School for various drug development projects [3] Digital Healthcare Development - Enhua Pharmaceutical has established a digital healthcare platform since 2015, which includes online consultation and health services, with over 70,000 registered doctors and more than 2 million patient visits annually [4] - The company has developed several digital mental health products, including AI-based psychological risk screening systems and virtual reality tools [4] Expansion and Partnerships - The company operates 25 psychological clinics and has signed contracts with over 400 corporate clients, covering nearly 2 million individuals [5] - Enhua Pharmaceutical is actively pursuing overseas listing plans to expand financing channels and support business growth [5]

Core Viewpoint - The deadline for the award application for the Global MedTech Innovation Awards has been extended to June 20, 2025, to allow more time for participants to prepare and submit their materials, aiming to showcase innovations and contributions in the medical device field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of around 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference will feature a main stage for showcasing and awarding global medical technology innovations [5]. Group 2: Award Categories - The awards to be presented include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, with results to be announced between June 30 and July 4, and the awards to be presented on July 17, 2025 [12]. - Participants must fill out a specific form or send an email with required details to apply for the awards [13]. Group 4: Evaluation Criteria - The awards are aimed at various entities including medical device companies, healthcare institutions, and service providers, with criteria focusing on originality, advanced technology, clinical application, and industry impact [7][10][11]. - Specific standards are set for each award category, emphasizing the need for innovative products or technologies that demonstrate clear clinical efficacy and potential for widespread application [10][11]. Group 5: Conference Agenda - The conference will cover topics such as global medical technology development trends, research and transformation paths for imaging platforms, new consumables, brain-machine interfaces, interventional devices, diagnostic equipment, and the integration of AI in healthcare [6]. - It will also address capital market interests in technology directions and enterprise profiles, as well as overseas market access and marketing strategies [6].

Core Viewpoint - The deadline for the award application for the Global MedTech Innovation Awards has been extended to June 20, 2025, to allow more time for participants to prepare and submit their materials, aiming to showcase innovations and contributions in the medical device field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of approximately 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference will feature a main stage for showcasing and awarding global medical technology innovations [5]. Group 2: Award Categories - The awards to be presented include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application and Evaluation Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, 2025, with results to be announced between June 30 and July 4, 2025 [11]. - The awards will be presented on July 17, 2025, after the confirmation of trophy production [11]. Group 4: Target Audience and Standards - The awards target various entities including medical device and digital health technology companies, clinical doctors, researchers, and key suppliers, with specific standards for originality, advancement, and potential for industrialization [7][10].

Core Viewpoint - The deadline for the award application for the Global MedTech Innovation Awards has been extended to June 20, 2025, to allow more time for participants to prepare and submit their materials, aiming to showcase innovations and contributions in the medical technology field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of approximately 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference will feature a main stage for showcasing and awarding global medical technology innovations [5]. Group 2: Award Categories - The awards to be presented include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application and Evaluation Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, with results to be announced between June 30 and July 4, and the awards to be presented on July 17, 2025 [11]. - Participants must meet specific criteria based on their roles, such as medical device companies, clinical doctors, researchers, and service providers, ensuring that the innovations are original, advanced, and have potential for large-scale industrialization [7][10].

Core Viewpoint - The article announces the extension of the application deadline for the Global MedTech Innovation Awards to June 20, 2025, to allow more time for participants to prepare their submissions and showcase their innovations in the medical technology field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of around 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference aims to highlight and award groundbreaking achievements in medical technology, with a focus on innovation, application, and service contributions [4][8]. Group 2: Award Categories - The awards include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, with results to be announced between June 30 and July 4 [11]. - Participants must submit specific documents including a personal resume, a summary of research achievements, and any relevant supporting materials [13].